Around one in ten people with HIV developed limited treatment options – which meant that they could no longer take a standard three-drug antiretroviral combination – during approximately five years of follow-up, a large study has found.
The most common reason for discontinuing previous antiretrovirals and needing a non-standard regimen was inability to tolerate drugs in the previous regimen, not virological failure of treatment. The study followed people who had been on treatment for at least five years, not people who were new to treatment, and those who developed limited treatment options had been taking antiretrovirals for a median of 13.5 years.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
[Press release] FDA grants priority review of New Drug Application for Gilead’s once-daily HIV treatment of bictegravir plus lenacapavir
-
[CROI 2026] HIV i-Base: Investigational HIV combinations – daily, weekly, 4- and 6-monthly…
-
[Press release] FDA approves Merck’s once-daily IDVYNSO™ (doravirine/islatravir)
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.